A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
Clinical trial NCT05181618 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05181618
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-20
- Primary completion
- 2027-11-30
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.